Recognition of illness associated with the intentional release of a biologic agent

JAMA

Volumn 286, Issue 17, 2001, Pages 2088-2090

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX; BIOLOGICAL WARFARE; BOTULISM; CLINICAL FEATURE; EBOLA VIRUS; ENVIRONMENTAL EXPOSURE; EPIDEMIC; HEALTH CARE PERSONNEL; HEALTH SURVEY; HEMORRHAGIC FEVER; INFECTION CONTROL; MARBURG VIRUS; PLAGUE; PRIORITY JOURNAL; SHORT SURVEY; SMALLPOX; TERRORISM; TULAREMIA; ARTICLE; DIAGNOSIS, MEASUREMENT AND ANALYSIS; HUMAN; LABORATORY DIAGNOSIS; PUBLIC HEALTH SERVICE; UNITED STATES; VIRUS HEMORRHAGIC FEVER;

ANTHRAX; BIOTERRORISM; BOTULISM; HEMORRHAGIC FEVERS, VIRAL; HUMANS; INFECTION CONTROL; LABORATORY TECHNIQUES AND PROCEDURES; PLAGUE; PUBLIC HEALTH ADMINISTRATION; SMALLPOX; SPECIMEN HANDLING; TULAREMIA; UNITED STATES;

EID: 0035824148     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.286.17.2088-JWR1107-2-1     Document Type: Short Survey

References (9)

1. Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001
2. Biological and chemical terrorism: Strategic plan for preparedness and response
3. Botulinum toxin as a biological weapon: Medical and public health management
4. Plague as a biological weapon: Medical and public health management
5. Small-pox as a biological weapon: Medical and public health management
6. Anthrax as a biological weapon: Medical and public health management
7. Tularemia as a biological weapon: Medical and public health management
8. Marburg and Ebola virus hemorrhagic fevers